Treating smoking dependence in depressed alcoholics.
Alcoholism and nicotine dependence share many neurobiological underpinnings; the presence of one drug can cause a person to crave the other. Depressive illness can complicate comorbid alcohol and nicotine dependence by exacerbating the negative affect encountered during attempts to abstain from one or both drugs. Given the morbidity and mortality associated with cigarette smoking, it is imperative to identify treatments to promote smoking cessation and address comorbid psychiatric conditions contemporaneously. Pharmacotherapeutic options demonstrating varying degrees of efficacy and promise in preclinical and clinical studies include nicotine replacement therapy (NRT), selective serotonin reuptake inhibitors (SSRIs), bupropion, varenicline, tricyclic antidepressants, and bupropion plus NRT. Topiramate has shown potential for promoting smoking cessation in alcoholics, although its safety in depressed patients has not been fully explored. The efficacy of medications for treating nicotine dependence is generally enhanced by the inclusion of behavioral interventions such as cognitive behavioral therapy. When group cohesion and social support are stressed, success rates increase among depressed smokers undergoing smoking cessation treatment. Additional treatment strategies targeting dually dependent individuals with comorbid psychiatric disorders, including special populations such as women and adolescents, await further investigation.
Ait-Daoud
Nassima
N
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia, USA.
Lynch
Wendy J
WJ
Penberthy
J Kim
JK
Breland
Alison B
AB
Marzani-Nissen
Gabrielle R
GR
Johnson
Bankole A
BA
D000437:Alcoholism / Q000453:epidemiology / Q000534:rehabilitation*; D000928:Antidepressive Agents / Q000008:administration & dosage; D016642:Bupropion / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D015897:Comorbidity; D003866:Depressive Disorder / Q000453:epidemiology / Q000534:rehabilitation*; D005632:Fructose / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage; D011615:Psychotherapy, Group; D016540:Smoking Cessation; D000077236:Topiramate
D000928:Antidepressive Agents; D016642:Bupropion; D000077236:Topiramate; D005632:Fructose; D009538:Nicotine